Bibliografija osebe. Seznam zajema vsa gradiva in ne le tista, kje je oseba mentor.

Doktorska dela (2)

1. Barbara Jenko Bizjan: Klinično farmakogenetski modeli za bolniku prilagojeno zdravljenje revmatoidnega artritisa
2. Blaž Krhin: Genetski označevalci raka Huerthlejevih celic ščitnice

Diplomska dela (2)

1. Maja Ota: Vpliv genetskih polimorfizmov encimov, ki odstranjujejo reaktivne kisikove spojine, na obolevnost za pljučnim rakom pri slovenskih bolnikih
2. Katarina Štrukelj: Vpliv genetskega polimorfizma ApoE na koncentracijo plazemskih lipoproteinov in na višino dnevnega odmerka varfarina

Druga dela (37)

1. Evangelia Eirini Tsermpini, Una Glamočlija, Fulden Ulucan-Karnak, Sara Redenšek Trampuž, Vita Dolžan: Molecular mechanisms related to responses to oxidative stress and antioxidative therapies in COVID-19
2. Evangelia Eirini Tsermpini, Anja Plemenitaš Ilješ, Vita Dolžan: Alcohol‐induced oxidative stress and the role of antioxidants in alcohol use disorder
3. David Vogrinc, Katja Goričar, Tanja Kunej, Vita Dolžan: Systematic search for novel circulating biomarkers associated with extracellular vesicles in Alzheimerʹs disease
4. Katarina Esih, Katja Goričar, Aneta Soltirovska Šalamon, Vita Dolžan, Zvonka Rener-Primec: Genetic polymorphisms, gene–gene interactions and neurologic sequelae at two years follow-up in newborns with hypoxic-ischemic encephalopathy treated with hypothermia
5. Cita Zupanc, Alenka Franko, Danijela Štrbac, Metoda Dodič-Fikfak, Viljem Kovač, Vita Dolžan, Katja Goričar: Serum calretinin as a biomarker in malignant mesothelioma
6. Katarina Štrukelj: Vpliv genetskega polimorfizma ApoE na koncentracijo plazemskih lipoproteinov in na višino dnevnega odmerka varfarina
7. David Vogrinc, Katja Goričar, Vita Dolžan: Genetic variability in molecular pathways implicated in Alzheimer's disease
8. Jasna Klen, Vita Dolžan: Glucagon-like peptide-1 receptor agonists in the management of type 2 diabetes mellitus and obesity
9. Katja Goričar, Marija Holcar, Nina Mavec, Viljem Kovač, Metka Lenassi, Vita Dolžan: Extracellular vesicle enriched miR-625-3p is associated with survival of malignant mesothelioma patients
10. Sara Redenšek Trampuž, Tanja Blagus, Maja Trošt, Vita Dolžan: Serotonin-related functional genetic variants affect the occurrence of psychiatric and motor adverse events of dopaminergic treatment in Parkinson’s disease
11. Danijela Štrbac, Vita Dolžan: Novel and future treatment options in mesothelioma
12. Jasna Klen, Vita Dolžan: Treatment response to SGLT2 inhibitors
13. Sara Redenšek Trampuž, Barbara Jenko Bizjan, Maja Trošt, Vita Dolžan: Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's disease
14. Tina Levstek, Teo Mlinšek, Marija Holcar, Katja Goričar, Metka Lenassi, Vita Dolžan, Bojan Vujkovac, Katarina Trebušak Podkrajšek: Urinary extracellular vesicles and their miRNA cargo in patients with Fabry nephropathy
15. David Badovinac, Katja Goričar, Hana Zavrtanik, Miha Petrič, Teja Lavrin, Nina Mavec, Vita Dolžan, Aleš Tomažič, Metka Lenassi: Plasma extracellular vesicle characteristics correlate with tumor differentiation and predict overall survival in patients with pancreatic ductal adenocarcinoma undergoing surgery with curative intent
16. Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan: Dopaminergic pathway genes influence adverse events related to dopaminergic treatment in Parkinson's disease
17. Sara Redenšek Trampuž, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan: Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson's disease
18. Jana Ferdin, Katja Goričar, Vita Dolžan, Ana Plemenitaš, Jeffrey Martin, Matija Boris Peterlin, Steven G Deeks, Metka Lenassi: Viral protein Nef is detected in plasma of half of HIV-infected adults with undetectable plasma HIV RNA
19. Anja Šoštarič, Barbara Jenko Bizjan, Nada Rotovnik-Kozjek, Darja Ovijač, Dušan Šuput, Irina Milisav, Vita Dolžan: Detection of metabolic syndrome burden in healthy young adults may enable timely introduction of disease prevention
20. Makedonka Atanasovska-Velkovska, Katja Goričar, Tanja Blagus, Vita Dolžan, Barbara Cvenkel: Association of genetic polymorphisms in oxidative stress and inflammation pathways with glaucoma risk and phenotype
21. Rok Herman, Nika Aleksandra Kravos, Mojca Jensterle Sever, Andrej Janež, Vita Dolžan: Metformin and insulin resistance
22. Jernej Gašperšič, Vita Dolžan: Viral and host genetic and epigenetic biomarkers related to SARS-CoV-2 cell entry, infection rate, and disease severity
23. Danijela Štrbac, Vita Dolžan: Matrix metalloproteinases as biomarkers and treatment targets in mesothelioma
24. Tina Levstek, Sara Redenšek Trampuž, Maja Trošt, Vita Dolžan, Katarina Trebušak Podkrajšek: Assessment of the telomere length and its effect on the symptomatology of Parkinson's disease
25. Katarina Esih, Katja Goričar, Zvonka Rener-Primec, Vita Dolžan, Aneta Soltirovska Šalamon: CARD8 and IL1B polymorphisms influence MRI brain patterns in newborns with hypoxic-ischemic encephalopathy treated with hypothermia
26. Barbara Jenko Bizjan, Matija Tomšič, Biljana Jekić, Vera Milić, Vita Dolžan, Sonja Praprotnik: Clinical pharmacogenetic models of treatment response to methotrexate monotherapy in Slovenian and Serbian rheumatoid arthritis patients
27. Rok Herman, Mojca Jensterle Sever, Andrej Janež, Katja Goričar, Vita Dolžan: Genetic variability in antioxidative and inflammatory pathways modifies the risk for PCOS and influences metabolic profile of the syndrome
28. Katja Goričar, Vita Dolžan, Metka Lenassi: Extracellular vesicles
29. Sara Redenšek Trampuž, Tilen Kristanc, Tanja Blagus, Maja Trošt, Vita Dolžan: Genetic variability of the vitamin D receptor affects susceptibility to Parkinson's disease and dopaminergic treatment adverse events
30. David Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan: Genetic polymorphisms in oxidative stress and inflammatory pathways as potential biomarkers in Alzheimer’s disease and dementia
31. Boštjan Petrič, Sara Redenšek Trampuž, Vita Dolžan, Milica Gregorič Kramberger, Maja Trošt, Nikola Maraković, Marko Goličnik, Aljoša Bavec: Investigation of paraoxonase-1 genotype and enzyme-kinetic parameters in the context of cognitive impairment in Parkinson’s disease
32. Ivana Sedej, Maja Štalekar, Magda Tušek-Žnidarič, Katja Goričar, Nika Kojc, Polona Kogovšek, Vita Dolžan, Miha Arnol, Metka Lenassi: Extracellular vesicle-bound DNA in urine is indicative of kidney allograft injury
33. Sara Redenšek Trampuž, David Vogrinc, Katja Goričar, Vita Dolžan: Shared miRNA landscapes of COVID-19 and neurodegeneration confirm neuroinflammation as an important overlapping feature
34. David Vogrinc, Milica Gregorič Kramberger, Andreja Emeršič, Saša Čučnik, Katja Goričar, Vita Dolžan: The association of selected GWAS reported AD risk loci with CSF biomarker levels and cognitive decline in Slovenian patients
35. Maruša Barbo, Blaž Koritnik, Lea Leonardis, Tanja Blagus, Vita Dolžan, Metka Ravnik-Glavač: Genetic variability in oxidative stress, inflammatory, and neurodevelopmental pathways: impact on the susceptibility and course of spinal muscular atrophy
36. Gašper Tonin, Vita Dolžan, Jasna Klen: Genetic and transcriptomic background of oxidative stress and antioxidative therapies in late complications of type 2 diabetes mellitus
37. Cita Zupanc, Alenka Franko, Danijela Štrbac, Viljem Kovač, Vita Dolžan, Katja Goričar: Serum calretinin and genetic variability as a prognostic and predictive factor in malignant mesothelioma